Compare NATR & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NATR | NAGE |
|---|---|---|
| Founded | 1972 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.2M | 239.0M |
| IPO Year | 1995 | 2010 |
| Metric | NATR | NAGE |
|---|---|---|
| Price | $12.56 | $2.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $30.50 | $12.08 |
| AVG Volume (30 Days) | 103.6K | ★ 424.6K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.00 | 81.82 |
| EPS | ★ 0.48 | 0.09 |
| Revenue | ★ $480,144,000.00 | $129,423,000.00 |
| Revenue This Year | $3.24 | $2.85 |
| Revenue Next Year | $4.74 | $16.67 |
| P/E Ratio | ★ $25.83 | $29.78 |
| Revenue Growth | 5.67 | ★ 29.95 |
| 52 Week Low | $12.31 | $2.67 |
| 52 Week High | $28.14 | $7.95 |
| Indicator | NATR | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 26.23 | 25.92 |
| Support Level | N/A | N/A |
| Resistance Level | $28.00 | $3.61 |
| Average True Range (ATR) | 0.32 | 0.09 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 17.54 | 1.09 |
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.